EUVIMEDEUVIMED entdecken
Crossref

Nicorandil mitigates arsenic trioxide‐induced lung injury via modulating vital signalling pathways SIRT1/PGC‐1α/TFAM, JAK1/STAT3, and miRNA‐132 expression

Basel A Abdel-Wahab, Dalia Zafaar, Mohammed Shafiuddin Habeeb, Ehab A M El-Shoura iD

British Journal of Pharmacology · 2024

DOI: 10.1111/bph.16414 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Pharmacology, 2024. Verfasst von Basel A Abdel-Wahab und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, College of Pharmacy, Najran University, Najran, Saudi Arabia. Hauptthemen laut MEDLINE: Nicorandil, STAT3 Transcription Factor, Sirtuin 1, Signal Transduction. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 84 Literaturangaben. Gefördert von: Ministry of Education and Deanship of Scientific Research at Najran University, Ministry of Education and the Deanship of Scientific Research at Najran University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Purpose Nicorandil, a selective opener of potassium channels, used to treat angina, has drawn attention for its potential in mitigating lung injury, positioning it as a promising therapeutic approach to treat drug‐induced lung toxicity. This study aimed to explore the protective role of nicorandil in arsenic trioxide (ATO)‐induced lung injury and to elucidate the underlying mechanistic pathways. Experimental Approach We assessed the effects of nicorandil (15 mg·kg −1 , p.o.) in a rat model of pulmonary injury induced by ATO (5 mg·kg −1 , i.p.). The assessment included oxidative stress biomarkers, inflammatory cytokine levels, and other biomarkers, including sirtuin‐1, sirtuin‐3, STAT3, TFAM, and JAK in lung tissue. Histological examination using H&E staining and molecular investigations using western blotting and PCR techniques were conducted. Key Results In our model of lung injury, treatment with nicorandil ameliorated pathological changes as seen with H&E staining, reduced tissue levels of toxicity markers, and exerted significant antioxidant and anti‐inflammatory actions. On a molecular level, treatment with nicorandil down‐regulated JAK, STAT3, PPARγ, Nrf2, VEGF, p53, and micro‐RNA 132 while up‐regulating Sirt1, 3, TFAM, AMPK, and ERR‐α in lung tissue. Conclusions and Implications The results presented here show nicorandil as a significant agent in attenuating lung injury induced by ATO in a rodent model. Nonetheless, further clinical studies are warranted to strengthen these findings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NicorandilSTAT3 Transcription FactorSirtuin 1Signal TransductionArsenic TrioxideMicroRNAsJanus Kinase 1Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaLung InjuryAnimalsMaleRatsTranscription FactorsDNA-Binding ProteinsRats, WistarRats, Sprague-DawleyOxidative Stress

Stichwörter der Autor:innen

AMPK/SIRT1/PGC‐1α/TFAM, JAK1/STAT3 pathwayarsenic trioxidemiRNA‐132nicorandiloxidative stresspulmonary injury

Substanzen

NicorandilSTAT3 Transcription FactorSirtuin 1Arsenic TrioxideMicroRNAsSirt1 protein, ratJanus Kinase 1Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaPpargc1a protein, ratStat3 protein, rat

Autor:innen und Institutionen

  • Department of Pharmacology, College of Pharmacy, Najran University, Najran, Saudi Arabia.
  • Department of Pharmacology and Toxicology, Faculty of Pharmacy, Modern University of Technology, and Information, Cairo, Egypt.
  • Department of Clinical Pharmacy, Faculty of Pharmacy, Al-Azhar University, Assiut Branch, Assiut, Egypt.

ORCID-Profile: Ehab A M El-Shoura

Förderung

  • Ministry of Education and Deanship of Scientific Research at Najran University
  • Ministry of Education and the Deanship of Scientific Research at Najran University

Zitieren

APA

Abdel-Wahab, B. A., Zafaar, D., Habeeb, M. S., & El-Shoura, E. A. M. (2024). Nicorandil mitigates arsenic trioxide‐induced lung injury via modulating vital signalling pathways SIRT1/PGC‐1α/TFAM, JAK1/STAT3, and miRNA‐132 expression. British Journal of Pharmacology. https://doi.org/10.1111/bph.16414

Vancouver

Abdel-Wahab BA, Zafaar D, Habeeb MS, El-Shoura EAM. Nicorandil mitigates arsenic trioxide‐induced lung injury via modulating vital signalling pathways SIRT1/PGC‐1α/TFAM, JAK1/STAT3, and miRNA‐132 expression. British Journal of Pharmacology. 2024. doi:10.1111/bph.16414

BibTeX
@article{AbdelWahab2024,
  author = {Abdel-Wahab, Basel A and Zafaar, Dalia and Habeeb, Mohammed Shafiuddin and El-Shoura, Ehab A M},
  title = {Nicorandil mitigates arsenic trioxide‐induced lung injury via modulating vital signalling pathways SIRT1/PGC‐1α/TFAM, JAK1/STAT3, and miRNA‐132 expression},
  journal = {British Journal of Pharmacology},
  year = {2024},
  doi = {10.1111/bph.16414}
}
Kostenlos starten →